These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 18548983)

  • 41. Montelukast as monotherapy in children with mild persistent asthma.
    Wu WF; Wu JR; Dai ZK; Tsai CW; Tsai TC; Chen CC; Yang CY
    Asian Pac J Allergy Immunol; 2009 Dec; 27(4):173-80. PubMed ID: 20232571
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of treatment with montelukast on in vitro interleukin-10 production of mononuclear cells of children with asthma.
    Stelmach I; Majak P; Jerzynska J; Kuna P
    Clin Exp Allergy; 2005 Feb; 35(2):213-20. PubMed ID: 15725194
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pilot study of oral montelukast added to standard therapy for acute asthma exacerbations in children aged 6 to 14 years.
    Nelson KA; Smith SR; Trinkaus K; Jaffe DM
    Pediatr Emerg Care; 2008 Jan; 24(1):21-7. PubMed ID: 18165796
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Asthma-related health care resource use among patients starting fluticasone or montelukast therapy.
    Allen-Ramey FC; Anstatt DT; Sajjan SG; Markson LE
    Pharmacotherapy; 2005 Dec; 25(12):1752-60. PubMed ID: 16305295
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of the leukotriene receptor antagonist montelukast (Singulair) in the management of dysmenorrhea in adolescents.
    Harel Z; Riggs S; Vaz R; Flanagan P; Harel D
    J Pediatr Adolesc Gynecol; 2004 Jun; 17(3):183-6. PubMed ID: 15125904
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast.
    Rabinovitch N; Strand M; Stuhlman K; Gelfand EW
    J Allergy Clin Immunol; 2008 Jun; 121(6):1365-71. PubMed ID: 18439662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ALOX5 promoter genotype and response to montelukast in moderate persistent asthma.
    Telleria JJ; Blanco-Quiros A; Varillas D; Armentia A; Fernandez-Carvajal I; Jesus Alonso M; Diez I
    Respir Med; 2008 Jun; 102(6):857-61. PubMed ID: 18339529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Successful and effective: Montelukast in clinical practice].
    Internist (Berl); 1999 Dec; 40(12 Suppl Montelukas):1-4. PubMed ID: 10635479
    [No Abstract]   [Full Text] [Related]  

  • 49. Short-course montelukast for intermittent asthma in children: a randomized controlled trial.
    Robertson CF; Price D; Henry R; Mellis C; Glasgow N; Fitzgerald D; Lee AJ; Turner J; Sant M
    Am J Respir Crit Care Med; 2007 Feb; 175(4):323-9. PubMed ID: 17110643
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Leukotriene antagonists].
    Mallet JP
    Allerg Immunol (Paris); 1999 Apr; 31(4):113-6. PubMed ID: 10370724
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adherence to montelukast versus inhaled corticosteroids in children with asthma.
    Carter ER; Ananthakrishnan M
    Pediatr Pulmonol; 2003 Oct; 36(4):301-4. PubMed ID: 12950042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions.
    Bisgaard H; Skoner D; Boza ML; Tozzi CA; Newcomb K; Reiss TF; Knorr B; Noonan G
    Pediatr Pulmonol; 2009 Jun; 44(6):568-79. PubMed ID: 19449366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Placebo-controlled study of montelukast and budesonide on short-term growth in prepubertal asthmatic children.
    Pedersen S; Agertoft L; Williams-Herman D; Kuznetsova O; Reiss TF; Knorr B; Dass SB; Wolthers OD
    Pediatr Pulmonol; 2007 Sep; 42(9):838-43. PubMed ID: 17659605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety, tolerability, and exploratory efficacy of montelukast in 6- to 24-month-old patients with asthma.
    van Adelsberg J; Moy J; Wei LX; Tozzi CA; Knorr B; Reiss TF
    Curr Med Res Opin; 2005 Jun; 21(6):971-9. PubMed ID: 15969897
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis.
    Philip G; van Adelsberg J; Loeys T; Liu N; Wong P; Lai E; Dass SB; Reiss TF
    J Allergy Clin Immunol; 2009 Nov; 124(5):942-8.e1-9. PubMed ID: 19748656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of montelukast on basophil releasability in patients with asthma.
    Sade K; Kivity S; Fireman E; Schwartz Y; Kivity S
    Isr Med Assoc J; 2005 Dec; 7(12):792-5. PubMed ID: 16382702
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Montelukast, a leukotriene receptor antagonist, in vernal keratoconjunctivitis associated with asthma.
    Lambiase A; Bonini S; Rasi G; Coassin M; Bruscolini A; Bonini S
    Arch Ophthalmol; 2003 May; 121(5):615-20. PubMed ID: 12742837
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reports of suicidality in clinical trials of montelukast.
    Philip G; Hustad C; Noonan G; Malice MP; Ezekowitz A; Reiss TF; Knorr B
    J Allergy Clin Immunol; 2009 Oct; 124(4):691-6.e6. PubMed ID: 19815114
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children.
    Kopriva F; Dzubak P; Potesil J; Hajduch M
    J Asthma; 2009 May; 46(4):366-70. PubMed ID: 19484671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Montelukast: new preparation. No current use in asthma.
    Prescrire Int; 1999 Oct; 8(43):131-4. PubMed ID: 11503835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.